BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19301310)

  • 1. Role of the VEGFR3/VEGFD receptor axis in TGFbeta1 activation of primary prostate cell lines.
    Goodyear SM; Kheyfets SB; Garcia FU; Stearns ME
    Prostate; 2009 Jun; 69(9):982-90. PubMed ID: 19301310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway.
    Jiang J; Sugimoto Y; Liu S; Chang HL; Park KY; Kulp SK; Lin YC
    Anticancer Res; 2004; 24(1):91-100. PubMed ID: 15015581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system.
    Lin SW; Ke FC; Hsiao PW; Lee PP; Lee MT; Hwang JJ
    Exp Cell Res; 2007 Feb; 313(3):602-13. PubMed ID: 17187779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mifepristone-induced secretion of transforming growth factor beta1-induced apoptosis in prostate cancer cells.
    Liang Y; Eid MA; El Etreby F; Lewis RW; Kumar MV
    Int J Oncol; 2002 Dec; 21(6):1259-67. PubMed ID: 12429976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta1 and TGF-beta2 strongly enhance the secretion of plasminogen activator inhibitor-1 and matrix metalloproteinase-9 of the human prostate cancer cell line PC-3.
    Konrad L; Scheiber JA; Schwarz L; Schrader AJ; Hofmann R
    Regul Pept; 2009 Jun; 155(1-3):28-32. PubMed ID: 19422858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium hydrogen exchanger and phospholipase D are required for alpha1-adrenergic receptor stimulation of metalloproteinase-9 and cellular invasion in CCL39 fibroblasts.
    Taves J; Rastedt D; Canine J; Mork D; Wallert MA; Provost JJ
    Arch Biochem Biophys; 2008 Sep; 477(1):60-6. PubMed ID: 18539131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of 17beta-estradiol on apoptosis, IGF system components and gelatinases A and B in prostate cancer cells (PC-3).
    Kanagaraj P; Vijayababu MR; Ilangovan R; Senthilkumar K; Venkataraman P; Aruldhas MM; Arunakaran J
    Clin Chim Acta; 2007 Feb; 377(1-2):70-8. PubMed ID: 17083925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual effect of transforming growth factor beta1 on cell adhesion and invasion in human placenta trophoblast cells.
    Zhao MR; Qiu W; Li YX; Zhang ZB; Li D; Wang YL
    Reproduction; 2006 Aug; 132(2):333-41. PubMed ID: 16885541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phage display selection of peptides that affect prostate carcinoma cells attachment and invasion.
    Romanov VI; Durand DB; Petrenko VA
    Prostate; 2001 Jun; 47(4):239-51. PubMed ID: 11398171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance.
    Tam CW; Chan KW; Liu VW; Pang B; Yao KM; Shiu SY
    J Pineal Res; 2008 Nov; 45(4):403-12. PubMed ID: 18637986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential production of latent transforming growth factor beta-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen.
    Dallas SL; Zhao S; Cramer SD; Chen Z; Peehl DM; Bonewald LF
    J Cell Physiol; 2005 Feb; 202(2):361-70. PubMed ID: 15389580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penta-O-galloyl-beta-D-glucose suppresses prostate cancer bone metastasis by transcriptionally repressing EGF-induced MMP-9 expression.
    Kuo PT; Lin TP; Liu LC; Huang CH; Lin JK; Kao JY; Way TD
    J Agric Food Chem; 2009 Apr; 57(8):3331-9. PubMed ID: 19320436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium.
    Diamond ME; Sun L; Ottaviano AJ; Joseph MJ; Munshi HG
    J Cell Sci; 2008 Jul; 121(Pt 13):2197-207. PubMed ID: 18544635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
    Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
    Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility.
    Massoner P; Colleselli D; Matscheski A; Pircher H; Geley S; Jansen Dürr P; Klocker H
    Endocr Relat Cancer; 2009 Sep; 16(3):795-808. PubMed ID: 19509068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
    Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
    J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
    Bose SK; Gibson W; Giri S; Nath N; Donald CD
    Prostate; 2009 Sep; 69(12):1334-42. PubMed ID: 19517575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sumoylation of Prox1 controls its ability to induce VEGFR3 expression and lymphatic phenotypes in endothelial cells.
    Pan MR; Chang TM; Chang HC; Su JL; Wang HW; Hung WC
    J Cell Sci; 2009 Sep; 122(Pt 18):3358-64. PubMed ID: 19706680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.
    Castellano G; Malaponte G; Mazzarino MC; Figini M; Marchese F; Gangemi P; Travali S; Stivala F; Canevari S; Libra M
    Clin Cancer Res; 2008 Nov; 14(22):7470-80. PubMed ID: 19010864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.